Security key
79400X107
SALARIUS PHARMACEUTICALS INC - COM NEW (SLRX)
CUSIP: 79400X107
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 10,112,982
- Total 13F value
- $10,694,000
- Share change
- -5,407,669
- SEC-reported price per share
- $1.06
- Number of holders
- 29
- Value change
- -$6,412,290
- Number of buys
- 13
- Number of sells
- 17
Report period
Q2 2021
Institutions
29
Top holders
10
SLRX full security history
Ownership snapshot
Full 13F holder table
Decoy Therapeutics Inc. SEC filings
Decoy Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sio Capital Management, LLC
Disclosed value leader
Sio Capital Management, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2021
13F
Highest disclosed value: $4,616,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Sio Capital Management, LLC has the largest disclosed position value at $4.62M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sio Capital Management, LLC's linked filing trail.
Disclosed position value
Top 5
Sio Capital Management, LLC
$4.62M
SILVERARC CAPITAL MANAGEMENT, LLC
$2.95M
Maven Securities LTD
$2.78M
AIGH Capital Management LLC
$2.66M
Granite Point Capital Management,...
$2.31M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sio Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$4,616,000
3,118,696 shares
|
— | 31 Mar 2021 |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$2,948,000
1,992,181 shares
|
— | 31 Mar 2021 |
| Maven Securities LTD |
13F
Company
|
—
denominator unverified
|
$2,776,000
1,926,035 shares
|
— | 31 Mar 2021 |
| AIGH Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$2,664,000
1,800,000 shares
|
— | 31 Mar 2021 |
| Granite Point Capital Management, L.P. |
13F
Company
|
—
denominator unverified
|
$2,314,000
1,563,561 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$2,102,000
1,420,532 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
10,112,982
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
31
Q2 2021 holders
29
Holder diff
-2
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|